Literature DB >> 12007738

Role of placenta growth factor in cardiovascular health.

Shalini Iyer1, K Ravi Acharya.   

Abstract

Placenta growth factor (PlGF), a member of the cysteine-knot family, is an angiogenic protein. The PlGF gene has been conserved across different species of the animal kingdom. It is expressed primarily in the placenta, especially in the later stages of gestation. PlGF expression is upregulated during pathological conditions such as ischemia of the heart and myocardial infarction. It is now known that PlGF can modulate the activity of vascular endothelial growth factor, the most potent of all angiogenic inducers and hence makes it an attractive target for therapeutic strategies. Recent structural studies on different isoforms of PlGF promise to reveal important topological and molecular details of these proteins that may be of potential use in the design of effective small molecule inhibitors to combat pathological angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12007738     DOI: 10.1016/s1050-1738(01)00164-5

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  9 in total

1.  Improvement of risk assessment in systemic light-chain amyloidosis using human placental growth factor.

Authors:  Arnt V Kristen; Johannes Rinn; Ute Hegenbart; David Lindenmaier; Corina Merkle; Christoph Röcken; Stefan Hardt; Evangelos Giannitsis; Hugo A Katus
Journal:  Clin Res Cardiol       Date:  2014-10-21       Impact factor: 5.460

Review 2.  Biomarkers of plaque instability.

Authors:  P K Shah
Journal:  Curr Cardiol Rep       Date:  2014-12       Impact factor: 2.931

3.  Placental growth factor: as an early second trimester predictive marker for preeclampsia in normal and high-risk pregnancies in a Turkish population.

Authors:  Necmiye Dover; Hacer C Gulerman; Sevki Celen; Serkan Kahyaoglu; Okan Yenicesu
Journal:  J Obstet Gynaecol India       Date:  2012-11-02

4.  Angiotensin II upregulates the expression of placental growth factor in human vascular endothelial cells and smooth muscle cells.

Authors:  Pingxi Pan; Hua Fu; Lingjun Zhang; He Huang; Fengming Luo; Wenchao Wu; Yingqiang Guo; Xiaojing Liu
Journal:  BMC Cell Biol       Date:  2010-05-26       Impact factor: 4.241

5.  A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate.

Authors:  Roberto Romero; Jyh Kae Nien; Jimmy Espinoza; David Todem; Wenjiang Fu; Hwan Chung; Juan Pedro Kusanovic; Francesca Gotsch; Offer Erez; Shali Mazaki-Tovi; Ricardo Gomez; Sam Edwin; Tinnakorn Chaiworapongsa; Richard J Levine; S Ananth Karumanchi
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01

Review 6.  Growth factor activation in myocardial vascularization: therapeutic implications.

Authors:  Robert J Tomanek; Wei Zheng; Xinping Yue
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

Review 7.  Tumour vascularization: sprouting angiogenesis and beyond.

Authors:  Femke Hillen; Arjan W Griffioen
Journal:  Cancer Metastasis Rev       Date:  2007-12       Impact factor: 9.264

8.  Systemic and coronary levels of CRP, MPO, sCD40L and PlGF in patients with coronary artery disease.

Authors:  Siew Wai Fong; Ling Ling Few; Wei Cun See Too; Boon Yin Khoo; Nik Nor Izah Nik Ibrahim; Shaiful Azmi Yahaya; Zurkurnai Yusof; Rosli Mohd Ali; Abdul Rashid Abdul Rahman; Get Bee Yvonne-Tee
Journal:  BMC Res Notes       Date:  2015-11-14

9.  Puerarin Reduces Radiation-Induced Vascular Endothelial Cell Damage Via miR-34a/Placental Growth Factor.

Authors:  Chang Liu; Ying Zhao; Xiaoting Xu; Lei Zhang; Fengmei Cui; Qiu Chen; Hongxia Li; Ru Sang; Gen Li; Yongming He
Journal:  Dose Response       Date:  2022-01-19       Impact factor: 2.658

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.